Patients using GLP-1 receptor agonists are reporting something unexpected: less joint and musculoskeletal pain. As interest grows in how GLP-1 therapies may affect chronic pain, clinicians are asking an important question. Are these improvements simply the result of weight loss, or do GLP-1 medications have direct anti-inflammatory and neuromodulatory effects? …
Read More »Deciphering Diabetic Neuropathy: Comprehensive Clinical Approaches
Diabetic neuropathy is a type of nerve damage caused by diabetes. It is a common complication of both Type 1 and Type 2 diabetes, and can affect the autonomic, motor, and sensory nerves. It is important to understand the cause and symptoms of diabetic neuropathy as well as the comprehensive …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.